The arrangement will allow medicines to be built inside the United States from start to finish, Phlow's CEO said.

The new funding helps Phlow accelerate its mission to help make ingredients for medicines either considered in short supply ...

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine ...

Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.

Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...